Effects of native banana starch supplementation on body weight and insulin sensitivity in obese type 2 diabetics

International Journal of Environmental Research and Public Health

Volumn 7, Issue 5, 2010, Pages 1953-1962

  Ble Castillo, Jorge L ^a   Aparicio Trapala, María A ^a   Francisco Luria, Mateo U ^b   Cordova Uscanga, Ruben ^b   Rodriguez Hernandez, Arturo ^a,d   Mendez, Jose D ^c   Diaz Zagoya, Juan C ^a  

^a UNIVERSIDAD JUÁREZ AUTÓNOMA DE TABASCO   (Mexico)

^b Hospital General de Zona IMSS   (Mexico)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Banana; Diabetes; Insulin resistance; Obesity; Resistant starch

Indexed keywords

INSULIN; NATIVE BANANA STARCH; STARCH; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BANANA; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DIETARY FIBER; FEMALE; FOOD INTAKE; GLYCEMIC CONTROL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SOYBEAN MILK; CHEMISTRY; COMPLICATION; DRUG EFFECTS; MIDDLE AGED; MUSA; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; BODY WEIGHT; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSA; OBESITY; STARCH;

EID: 77954767683     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph7051953     Document Type: Article

References (31)

1. Wild, S.; Roglic, G.; Green, A.; Sicree, R.; King, H. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27, 1047-1053.
2. Stumvoll, M.; Goldstein, B.J.; van Haeften, T.W. Type 2 diabetes, principles of pathogenesis and therapy. Lancet.2005, 365, 1333-1346.
3. Bray, G.A. Medical consequences of obesity. J. Clin. Endocrinol. Metab. 2004, 89, 2583-2589.
4. Reaven, G.; Abbasi, F.; McLaughlin, T. Obesity, insulin resistance, and cardiovascular disease. Recent. Prog. Horm. Res. 2004, 59, 207-223.
5. Wadden, T.A.; Berkowitz, R.I.; Womble, L.G.; Sarwer, D.B.; Phelan, S.; Cato, R.K.; Hesson, L.A.; Osei, S.Y.; Kaplan, R.; Stunkard, A.J. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N. Engl. J. Med. 2005, 353, 2111-2120.
6. McKeown, N.M.; Meigs, J.B.; Liu, S.; Wilson, P.W.; Jacques, P.F. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am. J. Clin. Nutr. 2002, 76, 390-398.
7. Liese, A.D.; Roach, A.K.; Sparks, K.C.; Marquart, L; D'Agostino, R.B., Jr.; Mayer-Davis, E.J. Whole-grain intake and insulin sensitivity, the Insulin Resistance Atherosclerosis Study. Am. J. Clin. Nutr. 2003, 78, 965-971.
8. Parillo, M.; Riccardi, G. Diet composition and the risk of type 2 diabetes, epidemiological and clinical evidence. Br. J. Nutr. 2004, 92, 7-19.
9. Slavin, J.L. Position of the American Dietetic Association, health implications of dietary fiber. J. Am. Diet. Assoc. 2008, 108, 1716-1731.
10. Fuentes-Zaragoza, E.; Riquelme-Navarrete M.J.; Sánchez-Zapata, E.; Pérez-Álvarez, J.A. Resistant starch as functional ingredient, a review. Food Res. Int. 2010, in press.
11. Topping, D.L.; Clifton, P.M. Short-chain fatty acids and human colonic function, roles of resistant starch and nonstarch polysaccharides. Physiol. Rev.2001, 81, 1031-1064.
12. Englyst, H.N.; Kingman, S.M.; Cummings, J.H. Classification and measurement of nutritionally important starch fractions. Eur. J. Clin. Nutr. 1992, 46, 33-50.
13. Pérez-Sánchez E. Efectos del consumo de una formulación que incluye almidón resistente de plátano en la glucemia postprandial de pacientes con diabetes mellitus tipo 2. Tesis de Maestría en Ciencias Alimentarias. Universidad Juárez Autónoma de Tabasco: Villahermosa, Tabasco, Mexico, 2007.
14. Flores-Gorosquera, E.; García-Suárez, F.J.; Flores-Huicochea, E; Nuñez-Santiago M.C.; González-Soto, R.A.; Bello-Pérez, L.A. Rendimiento del proceso en la extracción de almidón a partir de frutos de plátano (Musa paradisiaca). Estudio en planta piloto. Acta Cien. Venezol. 2004, 55, 86-90.
15. Goñi, I.; García-Diz, L.; Mañas, E.; Saura-Calixto, F. Analysis of resistant starch, a method for foods and food products. Food Chem. 1996, 56, 445-449.
16. Matthews, D.R.; Hosker, J.P.; Rudenski, A.S.; Naylor, B.A.; Treacher, D.F.; Turner, R.C. Homeostasis model assessment, insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28, 412-419.
17. Howarth, N.C.; Saltzman, E.; Roberts, S.B. Dietary fiber and weight regulation. Nutr. Rev. 2001, 59, 129-139.
18. Slavin, J.L.; Green, H. Fibre and satiety. Nutr. Bull. 2007, 32, 32-42.
19. Behall, K.M.; Scholfield, D.J.; Hallfrisch, J.G.; Liljeberg-Elmstahl, H.G. Consumption of both resistant starch and beta-glucan improves postprandial plasma glucose and insulin in women. Diabet. Care 2006, 29, 976-981.
20. Robertson, M.D.; Bickerton, A.S.; Dennis, A.L.; Vidal, H; Frayn, K.N. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am. J. Clin. Nutr. 2005, 82, 559-567.
21. Park, O.J.; Kang, N.E.; Chang, M.J.; Kim, W.K. Resistant starch supplementation influences blood lipid concentrations and glucose control in overweight subjects. J. Nutr. Sci. Vitaminol. (Tokyo) 2004, 50, 93-99.
22. Yki-Jarvinen, H.; Koivisto, V.A.; Ylikahri, R.; Taskinen, M.R. Acute effects of ethanol and acetate on glucose kinetics in normal subjects. Am. J. Physiol. 1988, 254, 175-180.
23. Reilly, K.J.; Frankel, W.L.; Bain, A.M.; Rombeau, J.L. Colonic short chain fatty acids mediate jejunal growth by increasing gastrin. Gut 1995, 37, 81-86.
24. Tappenden, K.A.; McBurney, M.I. Systemic short-chain fatty acids rapidly alter gastrointestinal structure, function, and expression of early response genes. Dig. Dis. Sci. 1998, 43, 1526-1536.
25. Poykko, S.; Ukkola, O.; Kauma, H.; Savolainen, M.J.; Kesaniemi, Y.A. Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects. Diabetologia 2003, 46, 455-458.
26. Choi, K.; Roh, S.G.; Hong, Y.H.; Shrestha, Y.B.; Hishikawa, D.; Chen, C.; Kojima, M.; Kangawa, K.; Sasaki, S. The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 2003, 144, 754-759.
27. Lavigne, C.; Marette, A.; Jacques, H. Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am. J. Physiol. Endocrinol. Metab. 2000, 278, 491-500.
28. Jayagopal, V.; Albertazzi, P.; Kilpatrick, E.S.; Howarth, E.M.; Jennings, P.E.; Hepburn, D.A.; Atkin, S.L. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabet. Care 2002, 25, 1709-1714.
29. Hermansen, K.; Sondergaard, M.; Hoie, L.; Carstensen, M.; Brock, B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabet. Care 2001, 24, 228-233.
30. Wang, Y.; Jones, P.J.; Ausman, L.M.; Lichtenstein, A.H. Soy protein reduces triglyceride levels and triglyceride fatty acid fractional synthesis rate in hypercholesterolemic subjects. Atherosclerosis 2004, 173, 269-275.
31. Ali, A.A.; Velasquez, M.T.; Hansen, C.T.; Mohamed, A.I.; Bhathena, S.J. Modulation of carbohydrate metabolism and peptide hormones by soybean isoflavones and probiotics in obesity and diabetes. J. Nutr. Biochem.2005, 16, 693-699.